AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Lilly and Boehringer Ingelheim announce availability of Jentadueto in US pharmacies.
(From Pharma)
M2PHARMA-March 8, 2012-Lilly and Boehringer Ingelheim announce availability of Jentadueto in US pharmacies (C)2012 M2 COMMUNICATIONS http://www.m2.com
Pharmaceutical product corporation Eli Lilly and Company (NYSE: LLY) and Boehringer Ingelheim Pharmaceuticals Inc announced on Wednesday that Jentadueto (linagliptin/metformin hydrochloride) tablets are now available by prescription in several leading chain and independent pharmacies across the US.
Jentadueto is a new prescription medication for patients who need to control their blood sugar.
Linagliptin is marketed in the US as Tradjenta 5mg once-daily tablets. Jentadueto was approved …
-
- Eli Lilly and Boehringer Ingelheim Announce Approval for Jentadueto...
-
News wire article from: Europe Intelligence Wire
July 26, 2012
700+ words
-
- Lily and Boehringer Ingelheim Pharmaceuticals announce FDA approval of...
-
News wire article from: Europe Intelligence Wire
January 31, 2012
700+ words
-
- Boehringer Ingelheim and Eli Lilly and Company Receive Marketing...
-
News wire article from: Europe Intelligence Wire
July 26, 2012
700+ words
-
- FDA clears Jentadueto tablets to lower blood sugar in patients with Type 2...
-
News wire article from: Europe Intelligence Wire
January 31, 2012
700+ words
